Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. De Backer (Antwerp, Belgium), C. Van Holsbeke (Antwerp, Belgium), W. Vos (Antwerp, Belgium), D. Belmans (Antwerp, Belgium), G. Leemans (Antwerp, Belgium), W. De Backer (Antwerp, Belgium). Proof of concept of a non-invasive screening tool to detect idiopathic pulmonary fibrosis (IPF) in an early stage. 5231

Member's Comments

No comment yet.

Related content which might interest you: A simple prognostic tool for idiopathic pulmonary fibrosis (IPF) Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Validation of a novel prognostic tool for idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis Year: 2010 Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? Source: Eur Respir J 2013; 41: 250-251 Year: 2013 Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? Source: Eur Respir J 2013; 41: 249-250 Year: 2013 PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery Source: Eur Respir Rev 2013; 22: 148-152 Year: 2013 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Twelve lung zones protocol of ultrasound mapping in idiopathic pulmonary fibrosis. Source: International Congress 2019 – Thoracic ultrasound in clinical practice Year: 2019 The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013 Prognostic evaluation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 141-146 Year: 2012 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Pirfenidone treatment for idiopathic pulmonary fibrosis (IPF): a comprehensive analysis of safety Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010 Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017